Aksigen IVF expands science-led fertility care with new integrated centre in Navi Mumbai

In September 2025, Aksigen IVF announced the launch of its 5,000 sq ft fertility center in Panvel, Maharashtra, as part of its expansion across Navi Mumbai, Raigad and neighboring regions. The center brings together advanced embryology, diagnostic services, personalised clinical pathways, digital laboratory systems and patient education under one roof. According to Aksigen IVF, the center has been designed around quality, transparency and clinical governance, with the aim of expanding access to evidence-based fertility care across Navi Mumbai, Raigad and neighboring regions.

A key feature of the Panvel center is the Bharat Daftary Knowledge Centre (BDKC), which is described by Aksigen IVF as the first immersive IVF Knowledge Centre of its kind in the Navi Mumbai and Raigad region. It is designed to help patients understand fertility, IVF treatment, and reproductive health through interactive and technology-enabled learning experiences.

It is also equipped with the LensHooke CASA X12 Pro, an AI-enabled semen analysis platform capable of assessing double-strand DNA Fragmentation Index (DFI). The platform provides objective and reproducible semen analysis to provide insights into male fertility and support treatment planning.

To strengthen patient safety, the center has also implemented RFID-based electronic witnessing with biometric verification, enabling traceability of biological samples throughout the IVF journey. The system is combined with manual double witnessing and digital documentation to support transparency and chain-of-custody protocols.

Impact on the Healthcare Market

The center offers fertility consultations and diagnostic services, supported by an embryology laboratory. The laboratory operates within validated environmental controls and follows SOP-driven workflows, with a focus on precision, consistency and patient safety. According to Aksigen IVF, this helps to support quality and reliability across all stages of the IVF journey, including fertilization, embryo culture and cryopreservation.

The center also provides assisted reproductive technologies, including In Vitro Fertilization (IVF), Intracytoplasmic Sperm Injection (ICSI), Intracytoplasmic Morphologically Selected Sperm Injection (IMSI), Preimplantation Genetic Testing (PGT/PGD), Laser Assisted Hatching, advanced embryo culture and cryopreservation.

Impact on the IVF Services Market

The global IVF services market size was estimated at USD 50.80 billion in 2025 and is predicted to increase from USD 54.10 billion in 2026 to approximately USD 95.36 billion by 2035, expanding at a CAGR of 6.50% from 2026 to 2035.

According to Precedence Research, the rising demand for fertility preservation services is expected to expand long-term treatment volumes globally, further driving market growth. Increasing influence of career priorities, delayed marriages, and lifestyle changes is encouraging individuals to opt for egg and sperm freezing. IVF providers are forming international partnerships to expand access, share expertise, and enable cross-border fertility care, improving treatment availability and standardization worldwide.

Innovations such as in vitro gametogenesis, egg rejuvenation, and AI-based embryo selection are gaining traction, with some already entering clinical use and further driving adoption and technological advancement in fertility care. Rapid establishment of specialized fertility centers across emerging regions is boosting access to assisted reproductive treatments.